🚀 In the fast-evolving world of biotech, Biointron is at the forefront of innovation, driving rapid advancements in #antibodydiscovery. 💡 Biointron's application of alpaca and llama #VHHantibodies supercharges their animal-based discovery platforms. When paired with phage display technology, these platforms operate with unparalleled speed and efficiency, expediting the discovery process like never before. Harnessing the power of #singleBcelltechnology, Biointron has achieved high-throughput capabilities that are simply astounding. This technology identifies antibodies with paired light and heavy chains in just 1-2 weeks. Biointron is doing more than just keeping up with the pace of #biotech innovation; they're setting it. The future of #therapeuticdevelopment is here, and it's happening now. 🧬💡 #SupplierOrchestration #ContractResearchOrganizations #Pharma #AnimalBasedDiscoveryPlatforms
Science Exchange’s Post
More Relevant Posts
-
Navigating the funding landscape can be tricky for biotech companies at all stages, from initial research and clinical trials to scaling up capabilities. Our recent roundtable discussions with over 90 Biotech CEOs, held in partnership with AusBiotech, shed light on the challenges and opportunities shaping the industry. Discover how to navigate the complexities of funding and innovation in the biotech sector in our latest article: https://okt.to/ugJm1o #Biotech #LifeSciences
-
-
Exciting insights from our recent roundtables, hosted in partnership with @AusBiotech. We were joined by more than 90 Biotech CEOs to discuss funding challenges, navigating regulatory changes, and talent acquisition. Read more about our discussions and how we can support your journey: https://lnkd.in/gwNc4P48
Navigating the funding landscape can be tricky for biotech companies at all stages, from initial research and clinical trials to scaling up capabilities. Our recent roundtable discussions with over 90 Biotech CEOs, held in partnership with AusBiotech, shed light on the challenges and opportunities shaping the industry. Discover how to navigate the complexities of funding and innovation in the biotech sector in our latest article: https://okt.to/ugJm1o #Biotech #LifeSciences
-
-
The biotech industry continues to grow and scale up, and biomanufacturing has become an increasingly important aspect of the field. As so many components are involved in producing biopharmaceuticals, microbial, cell-based or mRNA products, knowing where to start and with whom to partner is crucial. There are many things to keep in mind: 👉 staying up-to-date on the latest industry trends and advancements, 👉 ensuring the quality of the products, 👉 understanding of the regulatory landscape surrounding biomanufacturing, etc. Our panel will delve into a range of crucial topics that biotech companies inevitably encounter in their operations. Join us during #CEBioForum2024 conference: "How to handle biomanufacturing?" ❇️ Dr Adriana Kiędzierska - Mencfeld - Polpharma Biologics ❇️ Lukasz Paciorkowski - A4BEE ❇️ Dominik Lipka PhD Eng. - SyVento BioTech ❇️ Monika Kozdron-Sikorska - ExecMind. Life Science Executive Search #CEBioForum2024 #biomanufacturing #bioproduction
While #biotech is a fast changing subject, #biomanufacturing needs to keep up with this paste despite a number of obstacles that make it a highly challenging field. Why?... Listen to discussion "How to handle biomanufacturing?" between highly experience speakers during #CEBioForum2024 conference : ❇️ Monika Kozdron-Sikorska - ExecMind. Life Science Executive Search ❇️ Dr Adriana Kiędzierska - Mencfeld - Polpharma Biologics ❇️ Lukasz Paciorkowski - A4BEE ❇️ Dominik Lipka PhD Eng. - SyVento BioTech Let's find out what our guests recommend when it comes to: ✅ Challenges of scaling up – how to connect visionary ideas and real-world ✅ Internal technology transfer versus cooperation with CDMO ✅ Current and future trends in biomanufacturing Whant to bring your own perspective? JOIN US: 📅 26-27 March 2024, Warsaw 📍 Register here: https://lnkd.in/gmZqfBc2 #BiotechConference #discussion #Innovation #Biotechnology #Networking #CEBioForum2024 #CEBioForum
-
-
Ansa will re-define de-novo DNA synthesis. If you're not currently using them, you will be soon. #dna #dnasynthesis #syntheticbiology
Ansa Biotechnologies has been awarded the DNA Synthesis Technology of the Year award from BioTech Breakthrough. We're proud to be selected as one of this year’s standout biotech organizations. Thanks to #TeamAnsa for your hard work, perseverance and dedication to innovation. See the full list of honorees: https://lnkd.in/e-X3PCvE #BiotechBreakthrough #biotech #DNAsynthesis #synbio #EnzymaticDNAsynthesis
-
🔬✨ In this week's #TechTales post, we talk about the versatility of our MOFs in encapsulating and transporting various types of cargo for targeted drug delivery. At Vector Bioscience Cambridge, we customise our #NanoShuttles to optimise the encapsulation of any treatment, molecule, or combination of them. Our platform technology is cargo-agnostic, allowing for more precise and localised drug delivery and controlled drug release. This adaptability is crucial as it allows for the development of tailored therapies enhancing treatment effectiveness and patient outcomes. Stay tuned for our next #TechTales posts as we continue to explore the science driving our breakthroughs. 🚀🔗 #DrugDelivery #Nanotechnology #Biopharma #Biotech #Innovation #MOFs #CancerTreatment
-
Interesting summary from Chris Smyth - is digital biology here yet?
Optimised trial designs, improved endpoint selection, and proactive and timely communications with regulators will be important factors for biotech companies as they look to capitalise on increasing confidence in the sector in 2024. Fierce Biotech interviewed President of ICON Biotech, Chris Smyth, on his views on the state of play for biotech companies. Watch here: https://ow.ly/GHji50Qz5GM #biotech #BiotechStrategies #BiotechFuture
-
-
The BioNTX Facilities Advisory Committee joined with NexPoint and the Texas Research Quarter to welcome industry and regional innovators for a dynamic panel discussion on the pivotal role that North Texas plays in the future of healthcare and biotechnology innovation. Leaders highlighted the rapidly growing capabilities and incredible advancements happening locally, and addressed the challenges the region faces as it becomes increasingly competitive with other U.S. Biotech Hubs. BioNTX is wholly committed to fostering collaboration and driving forward the groundbreaking research happening in our region to improve the State’s economic development and patient outcomes. Together, we continue to push the boundaries and work together towards a healthier tomorrow! Learn more about the BioNTX Facilities Advisory Committee https://lnkd.in/gpJuygEC #innovation #lifescience #biotechnology #biotech #biomanufacturing #healthcare #lifesciences #research #bioscience #facilities #Texas #TRQ #Texas #TexasResearchQuarter #NorthTexas
-
-
Optimised trial designs, improved endpoint selection, and proactive and timely communications with regulators will be important factors for biotech companies as they look to capitalise on increasing confidence in the sector in 2024. Fierce Biotech interviewed President of ICON Biotech, Chris Smyth, on his views on the state of play for biotech companies. Watch here: https://ow.ly/GHji50Qz5GM #biotech #BiotechStrategies #BiotechFuture
-
-
Everything we do in #Biotech is hard, and sometimes outside forces make it harder. Here I dive into near-term critical issues that need the attention of the biotech community - https://lnkd.in/eCZU74KQ
Learn more: https://scienceexchange.pub/biointron